These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 8615179

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Zotepine in levodopa-induced Psychosis.
    Spieker S, Stetter F, Klockgether T.
    Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
    [No Abstract] [Full Text] [Related]

  • 8. [Levodopa dependency in Parkinson's disease: case report and review].
    Müller U, Reuter M, Hermann W, Gertz HJ.
    Nervenarzt; 2002 Sep; 73(9):887-91. PubMed ID: 12215883
    [Abstract] [Full Text] [Related]

  • 9. [Psychiatric complications of L-dopa: physiopathology and treatment].
    Castro-García A.
    Rev Neurol; 1997 Aug; 25 Suppl 2():S157-62. PubMed ID: 9280683
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clozapine for the treatment of levodopa-induced psychosis in Parkinson's disease.
    Rosenthal SH, Fenton ML, Harnett DS.
    Gen Hosp Psychiatry; 1992 Jul; 14(4):285-6. PubMed ID: 1505751
    [No Abstract] [Full Text] [Related]

  • 14. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
    Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M.
    Brain; 2008 Dec; 131(Pt 12):3380-94. PubMed ID: 18952677
    [Abstract] [Full Text] [Related]

  • 15. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
    Kum WF, Gao J, Durairajan SS, Man SC, Xie LX, Lu JH, Fong WL, Li M.
    J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
    [Abstract] [Full Text] [Related]

  • 16. L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
    Rascol O.
    Mov Disord; 1999 Aug; 14 Suppl 1():19-32. PubMed ID: 10493400
    [No Abstract] [Full Text] [Related]

  • 17. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
    Klivényi P, Vécsei L.
    Ideggyogy Sz; 2007 Jan 20; 60(1-2):61-4. PubMed ID: 17432097
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Diagnosis and therapy of Parkinson's disease].
    Wittstock M, Benecke R.
    MMW Fortschr Med; 2005 May 17; 147 Spec No 2():28-31. PubMed ID: 15968869
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.